WASHINGTON, March 6, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it willparticipate at the following upcoming investor conferences in March 2018.
The Cowen and Company 38th Annual Healthcare Conference in Boston on Monday,
The Oppenheimer 28th Annual Healthcare Conference in New York City on Tuesday, March 20, 2018. A corporate presentation is scheduled for 11:30 a.m. Eastern Time.
The corporate presentations given at the Cowen and Oppenheimer conferences will be available live on Vanda's corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:Jim Kelly Executive Vice President and Chief Financial Officer Vanda Pharmaceuticals Inc.(202) email@example.com
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-march-2018-investor-conferences-300609218.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All